Janssen Alzheimer Immunotherapy Research & Development, LLC
Overview
Janssen Alzheimer Immunotherapy Research & Development, LLC focuses on the research and development of therapeutic solutions for Alzheimer's disease. It is a subsidiary of Johnson & Johnson, a leading global healthcare company.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Janssen Alzheimer Immunotherapy Research & Development, LLC in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Janssen Alzheimer Immunotherapy Research & Development, LLC?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.